Tirabrutinib Maintenance Versus Placebo in Patients With Primary CNS Lymphoma in Complete Remission (JCOG2104)

Clinical trial NCT06940791 · RECRUITING

Trial details

NCT number: NCT06940791
Sponsor: Kyorin University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Central Nervous System Lymphoma

Start date: 2023-10-06
Primary completion: 2030-02-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.